Androgen receptor (AR) heterogeneity in prostate cancer and therapy resistance is a research paper published in Cancer Letters (2021). On theSindex it has a DataRank of 0. It has been cited 135 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: W81XWH-16-1-0575
National Institutes of Health
Grant: R01CA237027
National Institutes of Health
Grant: R01CA240290
National Institutes of Health
Grant: R21CA218635
National Institutes of Health
Grant: R21CA237939
National Institutes of Health
Grant: P30CA016056
FWCI
11.74
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Targeting PHB1 to inhibit castration-resistant prostate cancer progression in vitro and in vivo
Additional file 1 of Targeting PHB1 to inhibit castration-resistant prostate cancer progression in vitro and in vivo
Additional file 2 of Targeting PHB1 to inhibit castration-resistant prostate cancer progression in vitro and in vivo
Additional file 2 of Targeting PHB1 to inhibit castration-resistant prostate cancer progression in vitro and in vivo